Creating Asthma Measurements through the MORRE Study


Trial Objective

Creating Asthma Measurements through the MORRE StudyResearchers want to develop new ways to measure if a patient’s asthma is improving or worsening. During the study, participants will use a FitBit® to measure steps per day and sleep quality. Participants also will answer a custom survey using their own smartphone. Researchers hope to determine the best ways to show how well asthma is controlled while being treated with omalizumab, a common asthma medication.


Active Clinical Trials Currently Recruiting

Who Can Participate

Participants between 18 and 85 years of age with moderate-to-severe asthma at the time of enrollment, and who are eligible for omalizumab therapy.

Age: 18-85    Gender: Any Gender

Estimated Time Commitment

Participants will have a 2-3 in-person clinic visits of 45-90 minutes over 6-12 months.

Participants will also complete monthly surveys and questionnaires at home during the 12-month period.

Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Stephanie Leonard

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

National Jewish Health

Principal Investigators


Request More Information

By completing this form, you agree to learn more about this study and see if you qualify.

 I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: